FFO
MED icon

Fortitude Family Office’s Medifast MED Stock Holding History

Fortitude Family Office’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191 Buy
+18
New +$208 ﹤0.01% 2121
2025
Q4 		– Sell
-704
Closed -$9.62K – 2044
2025
Q3 		$9.62K Buy
704
+34
+5% +$475 ﹤0.01% 581
2025
Q2 		$9.41K Buy
+670
New +$8.8K ﹤0.01% 578

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fortitude Family Office's MED Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Medifast (MED) in Q2 2026: 18 shares worth $191. The stake represents ﹤0.01% of the portfolio and ranks #2121 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in MED as recently as Q3 2025.

Fortitude Family Office first reported a position in MED in Q2 2025 and has held it in 3 quarters since. The position peaked at $9.62K in Q3 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Fortitude Family Office held 18 shares of Medifast worth $191 as of Q2 2026.
  • Medifast was a new Fortitude Family Office position in Q2 2026.
  • Medifast made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2121 holding.
  • Fortitude Family Office first reported a position in Medifast in Q2 2025 and has held it in 3 quarters since.
  • Fortitude Family Office's Medifast position peaked at $9.62K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.